Accomplishments for 2009

SCCF submits the Continuation in Part (CIP) containing all our experimental results with human pediatric sickle cell patients’ blood to the U.S. Patent Office, March 15, 2009. The U.S. Patent on our sickle cell cure is issued the following month, 4/14/09. SCCF’s patents in the U.S., Canada, Australia, and the European Union (U.K., France, Germany, and Greece) are maintained, and their annuities paid. The Institutional Review Board (IRB) Protocol for our experiments with human blood from pediatric sickle cell patients is continued for 2009-2010, the 5th consecutive year for this approval rating by the OUHSC IRB for Protection of Human Subjects, acting ...

SCCF Takes On Sickle Cell Disease (SCD)

Somewhere, every minute, a baby dies of SCD. SCD is the most prevalent genetic disease globally. SCD occurs in many nations and among many races — wherever malaria was once or is still rampant. The Sickle Cell Cure Foundation has a cure for SCD. The SCCF’s cure will give SCD sufferers a normal life. The SCCF’s cure also provides malaria resistance. The SCCF has a global plan for cure distribution. The SCCF needs your help to save lives. What can you do? Become a Sickle Cell Cure Foundation member today. Donate NOW: help stop 500,000 deaths/year. Pass the word to your friends and acquaintances. Give generously and regularly. Why this cure will ...

Plan to cure Sickle Cell Disease

Plan to Cure or Ameliorate Sickle Cell Disease (SCD), Parkinson’s Disease (PD), and other diseases by Gene Regulation Therapy and Iron Management

Alicia and Dominick Bibbs

[caption id="attachment_221" align="alignleft" width="225" caption="Alicia & Dominick Bibbs"][/caption] Alicia Bibbs, an SCCF founder & research student, is pictured with her brother Dominick who suffers from sickle cell disease and recently recovered from surgery to have his spleen and gall bladder removed.

Radio Interview with Dr. Broyles

Dr. Broyles was interviewed by radio station KTOK on Easter Sunday April 12, 2009. To listen to the audio, click on the play button.[dewplayer:http://sicklecellcurefoundation.ecoonamoly.com/wp-content/uploads/2009/08/Dr._Robert_Broyles.mp3]

About SCCF

SCCF The Sickle Cell Cure Foundation, Inc. (SCCF) is a nonprofit corporation registered in the State of Oklahoma. Its 501(C) (3) status has been approved by the Internal Revenue Service of the United States as of February 12, 2007. Thus, all donations to the Foundation are tax-deductible. The date of SCCF’s incorporation was July 28, 2006. Read More →

SCCF Purpose

Sickle Cell Disease (SCD) affects more people in the world than any other genetic disease. Globally, almost one-half million babies die from SCD each year. We have discovered a treatment that promises permanent relief from the suffering, pain and premature death caused by SCD. We have devised a strong global plan for delivering this treatment and invite interested parties to join with The Sickle Cell Cure Foundation in this endeavor. General purpose: Education and scientific research. Specific purpose: The purpose of the SCCF is to bring the cure that we have discovered to clinics around the... [Read the full story]

Global Mission

Sickle cell disease (SCD) is a global problem. As the most common genetic disease in the world, SCD touches the lives of millions and affects many more. People of at least five racial groups and numerous ethnic origins have inherited the sickle gene. SCD is correctly classified as a “tropical disease”, since it is most common among populations living close to the equator, in tropical and subtropical regions. The populations in which SCD occurs most frequently live in Africa (which has about 75% of the cases), in Mediterranean countries, in the Middle East, and in India, with significant... [Read the full story]

MALARIA – SCD

HbF (fetal hemoglobin) suppresses the expression of sickle cell disease. In addition, a recent literature review by the imminent Dr. David Weatherall suggests that HbF protects infants from malaria during the first year of life,until HbF levels decline to modest levels through a normal developmental transition as quoted below: In vitro studies have shown that β-thalassaemic red cells are invaded at the same rate as normal red cells and that the rate of parasite growth is also indistinguishable from normal. However, both in human red cells and in transgenic mice carrying human γ-genes, it has... [Read the full story]

Corporate Partners

Executive Summaries (outlines) of “More Than Non-Profit”, “Non-Lucratif et Encore”, and “Beyond For-Profit Only” versions of our Business Plans are attached below. The full Business Plans (in three versions) are attached as PDFs below the Executive Summaries. Certified copies will be sent to entities or individuals who respond to our RFPP (Request for Proposals to Partner) and meet our criteria for serious consideration as partners in our global mission. More Than Non-Profit.pdf Non-Lucratif et Encore.pdf Beyond For-Profit Only.pdf BP More Than Non-Profit.pdf BP... [Read the full story]

Breaking News

Accomplishments for 2009

[Continue reading: Accomplishments for 2009]

SCCF Takes On Sickle Cell Disease (SCD)

[Continue reading: SCCF Takes On Sickle Cell Disease (SCD)]

Plan to cure Sickle Cell Disease

Plan to Cure or Ameliorate Sickle Cell Disease (SCD), Parkinson’s Disease (PD), and other diseases by Gene Regulation Therapy and Iron Management

[Continue reading: Plan to cure Sickle Cell Disease]

Alicia and Dominick Bibbs

Alicia & Dominick Bibbs Alicia Bibbs, an SCCF founder & research student, is pictured with her brother Dominick who suffers from sickle cell disease and recently recovered from surgery to have his spleen and gall bladder removed.

[Continue reading: Alicia and Dominick Bibbs]

Radio Interview with Dr. Broyles

Dr. Broyles was interviewed by radio station KTOK on Easter Sunday April 12, 2009. To listen to the audio, click on the play button.

[Continue reading: Radio Interview with Dr. Broyles]

World Sickle Cell Day

In celebration of World Sickle Cell Day , the SCCF announces its GLOBAL Request for Proposals to Partner (RFPP), attached as a PDF. RFPP-19-JUN-09[rev].pdf Abstract – United States Patent # 7,517,669 Issued April 14, 2009 A method is described for regulating gene expression related to iron metabolism to ameliorate...

[Continue reading: World Sickle Cell Day]

Clinical Trials

PRESS RELEASE No. 01 DATE: APRIL 2, 2009 CONTACT: ROBERT H. BROYLES, PhD E-MAIL: // robert <dot> broyles <at> sicklecellcurefoundation <dot> org // TELEPHONE : 001-405-922-5774 CURE FOR SICKLE CELL DISEASE PATENTED! U.S. RESEARCH FOUNDATION TO BEGIN CLINICAL TRIALS Scientists around the globe...

[Continue reading: Clinical Trials]

Read More Posts From Breaking News »

Sickle Cell Disease

Origins of Sickle Cell

Increasing fetal hemoglobin in people with homozygous sickle cell alleviates all symptoms of SCD. The Google map shows four independent genetic origins, or haplotypes, of SCD in different regions (ellipses) and the subsequent migrations of populations (white arrows). The solid white arrow is to signify the forced...

[Continue reading: Origins of Sickle Cell]

Facts About SICKLE CELL DISEASE (SCD)

Zoo Walk 2008 with SCCF posters and SCCF Board Member Gary Bricker in the background, and SCDAA Member Debra Jackson (center) and co-workers in the foreground. In the United States, SCD affects primarily people of African descent. But this pattern of prevalence is changing, with increasing numbers with SCD being found...

[Continue reading: Facts About SICKLE CELL DISEASE (SCD)]

Read More Posts From Sickle Cell Disease »